Company Overview and News

5
Local stocks end flat ahead of Fed policy review

2018-03-19 bworldonline
SHARES ended flat on Monday as investors chose to stay on the sidelines ahead of policy meetings by the local central bank and the United States’ Federal Reserve. The bellwether Philippine Stock Exchange index (PSEi) went down 0.03% or 2.61 points to finish at 8,235.54, paring early day losses that saw the gauge hit a low of 8,169.
PSKXF PHSXY PSE WPI

5
Pavilion guests accounted for; 5 casino employees killed in fire

2018-03-19 bworldonline
PHILIPPINE fire fighters said as of this reporting Monday the death toll from a fire in a hotel in the capital Manila had risen to five, after confirming two more fatalities and putting out the blaze a day after it broke out.
PSKXF PHSXY PSE WPI

5
Death toll in Philippine hotel fire rises to 5

2018-03-19 channelnewsasia
MANILA: Philippine firefighters said on Monday (Mar 19) the death toll from a fire in a hotel in the capital Manila had risen to five, after confirming two more fatalities and putting out the blaze a day after it broke out.
PSKXF PHSXY PSE WPI

 
3 killed in Manila Pavilion Hotel fire

2018-03-18 newsinfo.inquirer.net
Thick smoke billows from the 50 year old Manila Pavilion Hotel and Casino after it caught fire around 9:30 am on sunday. Firefighters are still investigating the cause of the fire, which reached Task force Bravo. INQUIRER/ MARIANNE BERMUDEZ
WPI

 
Four killed, some trapped as fire hits hotel in Philippine capital - Channel NewsAsia

2018-03-18 channelnewsasia
MANILA: A fire broke out at a hotel in the Philippine capital on Sunday, killing four people and trapping several on the fifth floor, a rescue official said.
WPI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:WPI / Waterfront Philippines, Incorporated on message board site Silicon Investor.

WPI: Watson Pharmaceuticals WPI: Watson Pharmaceuticals WPI: Watson Pharmaceuticals Western Pacific Gold WPI Western Pacific Gold WPI Western Pacific Gold WPI
Watson Pharmaceuticals Watson Pharmaceuticals Watson Pharmaceuticals WPI Watson Pharmaceuticals WPI Watson Pharmaceuticals WPI Watson Pharmaceuticals
WPI Group (WPIC) WPI Group (WPIC) WPI Group (WPIC) WESTERN PACIFIC GOLD - Solomon Islands Gold? WESTERN PACIFIC GOLD - Solomon Islands Gold? WESTERN PACIFIC GOLD - Solomon Islands Gold?